Our data show that Methylstat markedly decreases the mRNA expression levels of PDK1, AKT, and mTOR in glioma cells (Figure 6a,b), contributing to the suppression of the entire AKT/mTOR signaling cascade. The gene discussed is PDK1; the disease is central nervous system cancer.